EPSTEIN ROBERT S 4
4 · VERACYTE, INC. · Filed Nov 14, 2024
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
EPSTEIN ROBERT S
Director
Transactions
- Sale
Common Stock
2024-11-12$38.32/sh−15,000$574,830→ 44,598 total - Exercise/Conversion
Common Stock
2024-11-12$8.04/sh+15,000$120,600→ 59,598 total - Exercise/Conversion
Stock Option (right to buy)
2024-11-12−15,000→ 20,000 totalExercise: $8.04Exp: 2025-01-12→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 9, 2024.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $38.00 to $38.73. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F3]The option is fully vested.